3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Sarcoma
2
Xanthogranuloma, Juvenile
1
Sarcoma, Clear Cell
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Histiocytosis, Sinus
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Histiocytic Disorders, Malignant
1
Fallopian Tube Neoplasms
1
Erdheim-Chester Disease
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Breast Neoplasms
1
Interventions
temsirolimus
1
cobimetinib
1
Valproic Acid
1
Specimen Handling
1
Sirolimus
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Immunoglobulin G
1
Disulfides
1
Cetuximab
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Erdheim-Chester Disease
×
cobimetinib
×
Sarcoma
×
Clear all
NCT04079179
2025-09-18
NACHO-COBI
Baylor College of Medicine
Phase 2
Recruiting
90 enrolled